Skip to main content
. 2020 Mar 31;111(5):1478–1490. doi: 10.1111/cas.14374

Table 2.

Evaluation of viability and stability of iCAR‐NK/ILC during shipment

  Before transportation After transportation
Viability (%) Cell number/mL Viability (%) Cell number/mL
Lot 1 92 550 000 92 550 000
Lot 2 72 510 000 84 580 000
Lot 3 98 600 000 93 510 000